CVE Catalog

CVE-2026-21997

High
Published: Translated: NVD NIST

Summary

Vulnerability in the Oracle Life Sciences Empirica Signal product allows a low privileged attacker with network access via HTTP to compromise the system. Affected versions are 9.2.1-9.2.3 and may lead to unauthorized access to critical data.

Risk Assessment

Attacks may significantly impact additional products, increasing the risk of data integrity and confidentiality loss. Successful attacks can result in unauthorized creation, deletion, or modification of data.

Recommendation

It is recommended to update to the latest version of Oracle Life Sciences Empirica Signal to minimize the risk associated with this vulnerability. Additionally, monitoring data access and implementing further security measures is advised.

Related vulnerabilities

Original NVD description (English source)

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Vulnerability data from NVD (NIST) · CISA KEV · EPSS